A study assessing Ibutamoren in patients with pediatric growth hormone deficiency (PGHD)
Latest Information Update: 05 May 2021
At a glance
- Drugs Ibutamoren (Primary)
- Indications Somatotropin deficiency
- Focus Therapeutic Use
- Acronyms Merck 020 study
- 05 May 2021 New trial record
- 27 Apr 2021 According to a Lumos Pharma media release, data from this study was presented at the a virtual key opinion leader (KOL) event to be held today, April 27, 2021, at 10:30am ET.
- 27 Apr 2021 Results published in the Lumos Pharma Media Release